# Hypertonic Saline Use in Preeclampsia

> **NCT00181077** · PHASE1 · COMPLETED · sponsor: **Johns Hopkins University** · enrollment: 20 (—)

## Conditions studied

- Preeclampsia

## Interventions

- **DRUG:** 2% buffered hypertonic saline administration

## Key facts

- **NCT ID:** NCT00181077
- **Lead sponsor:** Johns Hopkins University
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2003-06
- **Primary completion:** 2006-04
- **Final completion:** 2006-04
- **Target enrollment:** 20 (—)
- **Last updated:** 2012-09-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00181077

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00181077, "Hypertonic Saline Use in Preeclampsia". Retrieved via AI Analytics 2026-07-31 from https://api.ai-analytics.org/clinical/NCT00181077. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*